Source comparison
Tesamorelin + Ipamorelin Blend: Protocol Comparison
Aggressive VAT Reduction 2mg daily 200mcg once daily Once daily (morning) 12–18% visceral fat reduction over 12–16 weeks; moderate muscle preservation Best for individuals with significant visceral adiposity (VAT >130cm² on imaging); requires protein intake ≥1
This comparison does not assign a generated winner or score.
- Aggressive VAT Reduction
- 2mg daily
- 200mcg once daily
- Once daily (morning)
- 12–18% visceral fat reduction over 12–16 weeks; moderate muscle preservation
- Best for individuals with significant visceral adiposity (VAT >130cm² on imaging); requires protein intake ≥1.8g/kg to prevent muscle loss
- Balanced Recomposition
- 1.5mg daily
- 250mcg twice daily
- Twice daily (morning + pre-sleep)
- 8–12% VAT reduction with lean mass preservation or 1–3% gain
- Optimal for moderate body fat (15–25%) seeking simultaneous fat loss and muscle retention; supports natural GH pulse pattern
- Lean Gain Emphasis
- 1mg daily
- 300mcg twice daily
- Twice daily (post-workout + pre-sleep)
- Modest VAT reduction (5–8%) with 2–4% lean mass gain
- Effective during controlled caloric surplus; ipamorelin's anabolic signaling dominates; best paired with resistance training
- Maintenance / Plateau Break
- 1mg EOD
- 3–4× weekly
- Prevents metabolic adaptation during extended deficits; 3–5% further VAT reduction
- Used after initial recomposition phase to sustain results without continuous daily dosing; reduces peptide cost and receptor sensitivity risk